1
|
Macrez R, Vivien D, Docagne F. [Role of endothelial NMDA receptors in a mouse model of multiple sclerosis]. Med Sci (Paris) 2017; 32:1068-1071. [PMID: 28044968 DOI: 10.1051/medsci/20163212008] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022] Open
Affiliation(s)
- Richard Macrez
- Normandie Univ, Unicaen, Inserm, physiopathology and imaging of neurological disorders (PhIND), boulevard Becquere, 14000 Caen, France
| | - Denis Vivien
- Normandie Univ, Unicaen, Inserm, physiopathology and imaging of neurological disorders (PhIND), boulevard Becquere, 14000 Caen, France - Service de biologie, délégation recherche clinique et innovation, centre hospitalier universitaire de Caen, 14000 Caen, France
| | - Fabian Docagne
- Normandie Univ, Unicaen, Inserm, physiopathology and imaging of neurological disorders (PhIND), boulevard Becquere, 14000 Caen, France
| |
Collapse
|
2
|
Le Guen E, Doukhan R, Hamdani N, Tamouza R, Groc L, Honnorat J, Leboyer M. [Anti-NR1 antibodies in anti-N-methyl-D-aspartate receptor encephalitis and schizophrenia]. Med Sci (Paris) 2015; 31:60-7. [PMID: 25658732 DOI: 10.1051/medsci/20153101014] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/17/2023] Open
Abstract
The recent discovery of anti-NMDA receptor antibodies and proof of their pathogenic effects in limbic encephalitides raised many questions among neuroscientist and physicians working in the field of schizophrenia. Indeed, this two conditions share several major clinical, pathophysiological or etiological aspects and some authors tend to consider some forms of schizophrenia as mild-encephalitis cases. Some studies have reported the presence of these antibodies in schizophrenic patient's sera without neurological symptoms. These findings suggest new therapeutic perspectives in some schizophrenic patients, despite a low seroprevalence and pathogenic effects that remain to be demonstrated.
Collapse
Affiliation(s)
- Emmanuel Le Guen
- Pôle psychiatrie des hôpitaux universitaires Henri Mondor, AP-HP, université Paris-Est, DHU PePSY, hôpital Albert Chenevier, 40, rue de Mesly, 94000 Créteil, France - Inserm U955, équipe 15, psychiatrie génétique, Créteil, France - fondation FondaMental, Créteil, France
| | - Raphaël Doukhan
- Pôle psychiatrie des hôpitaux universitaires Henri Mondor, AP-HP, université Paris-Est, DHU PePSY, hôpital Albert Chenevier, 40, rue de Mesly, 94000 Créteil, France - Inserm U955, équipe 15, psychiatrie génétique, Créteil, France - fondation FondaMental, Créteil, France
| | - Nora Hamdani
- Pôle psychiatrie des hôpitaux universitaires Henri Mondor, AP-HP, université Paris-Est, DHU PePSY, hôpital Albert Chenevier, 40, rue de Mesly, 94000 Créteil, France - Inserm U955, équipe 15, psychiatrie génétique, Créteil, France - fondation FondaMental, Créteil, France
| | - Ryad Tamouza
- laboratoire Jean Dausset d'immunologie et d'histocompatibilité, hôpital Saint Louis, Paris, France - LabEx Transplantex, Inserm UMRS 1160, Paris, France - université Paris Diderot, Paris, France
| | - Laurent Groc
- institut interdisciplinaire de neuroscience, CNRS UMR 5297, université de Bordeaux, Bordeaux, France
| | - Jérôme Honnorat
- centre de référence maladies rares « syndromes neurologiques paranéoplasiques », Hospices civils de Lyon, hôpital neurologique, Bron, France - Inserm U1028/CNRS UMR 5292, centre de recherché en neurosciences de Lyon, Bron, France - université de Lyon, université Claude-Bernard Lyon-1, Lyon, France
| | - Marion Leboyer
- Pôle psychiatrie des hôpitaux universitaires Henri Mondor, AP-HP, université Paris-Est, DHU PePSY, hôpital Albert Chenevier, 40, rue de Mesly, 94000 Créteil, France - Inserm U955, équipe 15, psychiatrie génétique, Créteil, France - fondation FondaMental, Créteil, France
| |
Collapse
|